Alnylam Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| State or Government | 84,605 | 0.0656% |
| Individual Insiders | 459,994 | 0.357% |
| General Public | 2,671,061 | 2.07% |
| Institutions | 125,765,257 | 97.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.8%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 26,147,703 | R$37.2b | 16.2% | 0.3% | |||
| 14,357,609 | R$20.4b | 20.7% | 0.2% | |||
| 12,635,096 | R$18.0b | 1.02% | 0.04% | |||
| 9,707,418 | R$13.8b | 1.67% | 0.04% | |||
| 6,591,087 | R$9.4b | -0.76% | 0.14% | |||
| 4,953,347 | R$7.0b | -20.2% | 0.19% | |||
| 4,887,000 | R$6.9b | -19% | 0.52% | |||
| 3,622,535 | R$5.2b | -4.17% | 0.29% | |||
| 3,468,315 | R$4.9b | -1.88% | 0.03% | |||
| 2,296,781 | R$3.3b | 0% | 0.04% | |||
| 2,147,203 | R$3.1b | 3.22% | 0.04% | |||
| 1,823,933 | R$2.6b | 10.9% | 0.05% | |||
| 1,592,733 | R$2.3b | 17.6% | 0.18% | |||
| 1,268,112 | R$1.8b | 75.9% | 0.88% | |||
| 960,959 | R$1.4b | 3.74% | 0.04% | |||
| 861,902 | R$1.2b | -13.1% | 0.02% | |||
| 809,095 | R$1.2b | -12% | 2.37% | |||
| 805,673 | R$1.1b | 0% | 0.82% | |||
| 734,919 | R$1.0b | -5.88% | 0.03% | |||
| 664,722 | R$945.0m | -12.4% | 0.14% | |||
| 597,026 | R$848.8m | 2.48% | 0.03% | |||
| 593,320 | R$843.5m | -19.5% | 0.03% | |||
| 544,638 | R$774.3m | 86.2% | 0.03% | |||
| 525,303 | R$746.8m | -7.73% | 0.16% | |||
| 491,096 | R$698.2m | 98.8% | 0.16% |